✦ LIBER ✦

180 Involvement of Asymmetric Dimetylarginine (ADMA), An Endogenous Inhibitor of Nitric Oxide (NO) Synthase, in the Pathogenesis of Acute Gastric Lesions

✍ Scribed by Slawomir Kwiecien; Tomasz Brzozowski; Peter C. Konturek; Robert Pajdo; Agata Ptak-Belowska; Wladyslaw Bielanski; Stanislaw Konturek; Wieslaw W. Pawlik

Book ID: 119430008
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(09)60151-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1694 Role of Asymmetric Dimetylarginine

W1694 Role of Asymmetric Dimetylarginine (ADMA), an Endogenous Inhibitor of Nitric Oxide (NO) Synthase in the Pathogenesis of Ischemia-Reperfusion Injury and Healing of Preexisting Gastric Ulcers

✍ Kwiecien, Slawomir; Brzozowski, Tomasz; Pajdo, Robert; Majka, Jolanta; Konturek, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Inflammation is an important determinant

Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure

✍ Rajeshwar P. Mookerjee; R. Neil Dalton; Nathan A. Davies; Stephen J. Hodges; Cha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Acute liver failure (ALF) is characterized by rapid progressive organ failure and poor outcome. The pathophysiology of multiorgan dysfunction in ALF remains unclear but increased systemic inflammatory response is believed to be an important determining factor. Asymmetric dimethylarginine (ADMA), an

Plasma levels of asymmetric dimethylargi

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

✍ J. B. Schnog; T. Teerlink; F. P. L. van der Dijs; A. J. Duits; F. A. J. Muskiet 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 103 KB

Cardiovascular effects of the endogenous

Cardiovascular effects of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) and evidence for ADMA metabolism in humans in vivo

✍ Achan, Vinod; Broadhead, Michael; Malaki, Mohammed; Leiper, James; MacAllister, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Modulatory role of the endogenous nitric

Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice

✍ Ozgur Gunduz; Cetin Hakan Karadag; Ahmet Ulugol 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 255 KB

O35. Asymmetric dimethylarginine (ADMA),

O35. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, increases the risk of cardiovascular disease and mortality in humans

✍ Rainer H. Boger 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB